Cargando…
Optimising the ECMO treatment regimen increases the survival rate for adult patients with acute fulminant myocarditis: A single-centre retrospective cohort study
BACKGROUND: Applying Extracorporeal membrane oxygenation (ECMO) to patients with acute fulminant myocarditis (AFM) reduces their mortality. The survival rate is 55.6-71.9% for adult AFM patients, which is lower than that for paediatric patients (63-81%). In our centre, the survival rate of ECMO for...
Autores principales: | Hou, Liusheng, Liang, Hongkai, Zeng, Shiyong, Li, Jianwei, Chen, Zhou, Liao, Xiaozu, Liu, Shaozhong, Li, Mingxing, Li, Binfei, Yuan, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060512/ https://www.ncbi.nlm.nih.gov/pubmed/37007790 http://dx.doi.org/10.3389/fmed.2023.1146570 |
Ejemplares similares
-
First successful treatment of a COVID-19 pregnant woman with severe ARDS by combining early mechanical ventilation and ECMO
por: Hou, Liusheng, et al.
Publicado: (2021) -
Fulminant myocarditis in COVID-19 and favorable outcomes with VA-ECMO
por: Bhardwaj, Abhishek, et al.
Publicado: (2022) -
ECMO as an effective rescue therapeutic for fulminant myocarditis complicated with refractory cardiac arrest
por: Li, Ya-Ting, et al.
Publicado: (2017) -
Cardiogenic Shock in COVID 19 Fulminant Myocarditis Treated with V-A ECMO
por: D'Errico Ramirez, A., et al.
Publicado: (2022) -
Case report: VA-ECMO for fulminant myocarditis in an infant with acute COVID-19
por: Hsu, Hao-Ting, et al.
Publicado: (2023)